Treatments and outcomes for end-stage renal disease following Wilms tumor
- 334 Downloads
Little is known about treatment outcomes for children who have end-stage renal disease (ESRD) after treatment for Wilms tumor (WT).
Time-to-transplant, graft failure, and survival outcomes were examined for 173 children enrolled on the National Wilms Tumor Study who developed ESRD.
Fifty-five patients whose ESRD resulted from progressive bilateral WT (PBWT) experienced high early mortality from WT that limited their opportunity for transplant (47% at 5 years) and survival (44% at 10 years) in comparison to population controls. The 118 patients whose ESRD was due to other causes (termed “chronic kidney disease”), many of whom had WT-associated congenital anomalies, had transplant (77% at 5 years) and survival (73% at 10 years) outcomes no worse than those for population controls. Graft failure following transplant was comparable for the two groups. Minority children had twice the median time to transplant as non-Hispanic whites and twice the mortality rates, also reflecting population trends.
In view of the continuing high mortality in patients with ESRD, and the dramatic improvement in outlook following kidney transplantation, re-evaluation of current guidelines for a 2-year delay in transplant following WT treatment may be warranted.
KeywordsChronic kidney failure Transplantation Graft failure
This study was supported in part by grant CA054498 from the United States National Cancer Institute. We thank investigators of the Children’s Oncology Group and the health professionals who managed the care of children entered in the National Wilms Tumor Study.
- 2.Dome JS, Perlman EJ, Ritchey ML, Coppes MJ, Kalapurakal JA, Grundy PE (2005) Renal tumors. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, 5th edn. Lippincott, Williams & Wilkins, Philadelphia, pp 905–932Google Scholar
- 8.EBPG Expert Group (2002) SECTION IV: Long-term management of the transplant recipient. Nephrol Dial Transplant 17:1–67Google Scholar
- 16.US Renal Data System (2009) USRDS 2009 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, pp 1–421Google Scholar
- 17.Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:456–481Google Scholar
- 19.Cox DR (1972) Regression models and life-tables (with discussion). J R Stat Soc B 34:187–220Google Scholar
- 21.Crowley J, Hu M (1977) Covariance analysis of heart transplant survival data. J Am Stat Assoc 72:27–36Google Scholar
- 23.R Development Core Team (2010) R: a language and environment for statistical computing. R Foundation for Statistical Computing, ViennaGoogle Scholar
- 24.US Renal Data System (2010) Pediatric ESRD. USRDS 2010 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, pp 325–334Google Scholar
- 27.US Renal Data System (2009) Morbidity and mortality. USRDS 2009 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, pp 269–280Google Scholar
- 29.Engels EA, Pfeiffer RM, Fraumeni JF, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306:1891–1901PubMedCrossRefGoogle Scholar